JNJ P/E Ratio
Share price divided by earnings per share — what investors pay for each dollar of profit.
P/E Ratio
Latest: 29.4 (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | 20.2 |
| 2020Q4 | 24.8 |
| 2021Q1 | 25.4 |
| 2021Q2 | 21.8 |
| 2021Q3 | 21.3 |
| 2021Q4 | 19.5 |
| 2022Q1 | 21.4 |
| 2022Q2 | 23.3 |
| 2022Q3 | 20.6 |
| 2022Q4 | 23.9 |
| 2023Q1 | 29.8 |
| 2023Q2 | 31.0 |
| 2023Q3 | 10.8 |
| 2023Q4 | 10.7 |
| 2024Q1 | 9.3 |
| 2024Q2 | 8.7 |
| 2024Q3 | 22.6 |
| 2024Q4 | 21.1 |
| 2025Q1 | 18.0 |
| 2025Q2 | 16.1 |
| 2025Q3 | 17.8 |
| 2025Q4 | 18.7 |
| 2026Q1 | 28.3 |
| 2026Q2 | 29.4 |
Other JNJ Charts
More quarter-by-quarter fundamentals for Johnson & Johnson
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Latest P/E Ratio: 29.4 (2026Q2); +82.6% YoY; +8.3% CAGR since 2011Q1 (15.25y).
Across the 62 quarters from 2011Q1 to 2026Q2, P/E Ratio ranged from 8.7 in 2024Q2 to 286.5 in 2017Q4.
Chart and table show the latest 24 of 62 quarters.